Hospital-based, case-control study to assess the vaccine effectiveness of Rotarix against rotavirus severe gastroenteritis among hospitalised children born after 1 March 2006 and at least 12 weeks of age, in Panama.
Phase of Trial: Phase III
Latest Information Update: 17 Mar 2011
At a glance
- Drugs RIX 4414 (Primary)
- Indications Rotavirus infections
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 18 Apr 2009 Actual patient number (263) added as reported by ClinicalTrials.gov.
- 18 Apr 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Apr 2009 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.